Sign up for Table of Contents Alerts.
Email this page
Print this page
Report
A Transgenic Mouse Model for High Content, Cell Cycle Phenotype Screening in Live Primary Cells
Richard O. Burney, Alan I. Lee, Denise E. Leong, Joshua T. Jones, Angela T. Hahn, Tobias Meyer and Mylene W.M. Yao
volume 6 | issue 18
15 September 2007Pages: 2276 - 2283
This is an open-access article
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
High content cell-based genetic and small molecule library screens are powerful strategies in drug discovery and investigations of disease mechanisms. We report that primary cells derived from a transgenic mouse model expressing a fluorescence mitosis biosensor provide unambiguous phenotype readouts without the need for transfection or immunocytochemistry. Phenotype profiles of cell cycle disruption and of apoptosis are easily detectable at a single time point selected from time-lapse live fluorescence microscopy. Most importantly, this transgenic mouse model may be crossed with cancer mouse models to derive biosensor-expressing primary cancer cells for use in high content screening strategies targeting discovery of tumor-specific chemotherapeutic compounds.
Authors
Richard O. Burney
Stanford University; Stanford, California
Alan I. Lee
Stanford University; Stanford, California
Denise E. Leong
Stanford University; Stanford, California
Joshua T. Jones
Stanford University; Stanford, California
Angela T. Hahn
Stanford University; Stanford, California
Tobias Meyer
Stanford University; Stanford, California
Mylene W.M. Yao
Stanford University; Stanford, California
This is an open-access article
If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.









